Identification and characterization of the 5-HT4 receptor in the intestinal tract and striatum of the guinea pig

Life Sciences

Volumn 59, Issue 25-26, 1996, Pages 2129-2137

  Uchiyama Tsuyuki, Yoshimi ^a   Saitoh, Masako ^a   Muramatsu, Makoto ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

5 HT4 receptor; guinea pig; intestinal tract; longitudinal muscle with myenteric plexus; striatum

Indexed keywords

1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; SEROTONIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; GUINEA PIG; INTESTINE; MYENTERIC PLEXUS; NONHUMAN;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0030589134     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(96)00569-3     Document Type: Article

References (21)

1. 1. J. BOCKAERT, M. SEBBEN and A. DUMUIS Mol. Pharmacol. 37 408-411 (1990).
2. 2. J. BOCKAERT, J.R. FOZARD, A. DUMUIS and D.E. CLARKE, Trends Pharmacol. Sci. 13 141-145 (1992).
3. 3. A. DUMUIS, R. BOUHELAL, M. SEBBEN, R. CORY and J. BOCKAERT, Mol.Pharmacol. 34 880-887 (1988).
4. 4. D.A. CRAIG and D.E. CLARKE, J.Pharmacol.Exp.Ther. 252 1378-1386 (1990).
5. 5. K. TANIYAMA, S. NAKAYAMA, K. TAKEDA, S. MATSUYAMA, J. SHIRAKAWA, , I. SANO and C. TANAKA, J.Pharmacol.Exp.Ther. 261 412-419 (1991).
6. 6. R.M. EGLEN, S.R. SWANK, L.K.M. WALSH and R.L. Whiting, Br.J.Pharmacol. 101 513-520 (1990).
7. 7. C.L. ELSWOOD, K.T. BUNCE and P.P.A. HUMPHREY. Eur.J.Pharmacol. 196 149-155 (1991).
8. 8. C.A. RIZZI, T. COCCINI, L. ONORI, L. MANZO and M. TONINI, J.Pharmacol.Exp.Ther. 1992 412-419 (1992).
9. 9. K.T. BUNCE, C.J. ELSWOOD and M.T. BALL, Br.J.Pharmacol. 102 811-816 (1991).
10. 10. J.J. REEVES, K.T. BUNCE and P.P.A. HUMPHREY, Br.J.Pharmacol. 103 1067-1072 (1991).
11. 11. A.H. BOM, D.J. DUNCKER, P.R. SAXENA and P.D. VERDOUW, Br.J. Pharmacol. 93 663-671 (1988).
12. 12. C.M. VILLALON, M.O. DENBOER, J.P.C. HEILIGERS and P.R. SAXENA, Br.J.Pharmacol. 100 665-667 (1990).
13. 13. A.J. KAUMANN, E. SANDERS, A.M. BROWN, K.J. MURRAY and N.J. BROWN, Br.J. Pharmacol. 100 879-885 (1990).
14. 14. A.J. KAUMANN, TIPS 15 451-455 (1994).
15. 15. L. FAGNI, A. DUMUIS, M. SEBBEN and J. BOCKAERT, Br.J.Pharmacol. 105 973-979 (1992).
16. 16. H. QUADID, J. SEGUIN, A. DUMUIS, J. BOCKAERT, and J. NARGEOT, Mol. Pharmacol. 41 346-351 (1992).
17. 17. C.J. GROSSMAN, G.J. KILPATRICK and K.T. BUNCE, Br.J. Pharmacol. 109 618-624 (1993).
18. 18. J. GLOWINSKI and L.L. IVERSEN, J.Neurochcm. 13 655-669 (1966).
19. 19. M.M. BRADFORD, Anal.Biochcm. 72 248-254 (1976).
20. 20. Y.C. CHENG and W.H. PRUSOFF, Biochcm. Pharmacol. 92 881-894 (1973).
21. 21. C. GERALD, N. ADHAM. H.-T. KAO, M.A. OLSEN, T.M. LAZ, L.E. SCHECHTER, J.A. BARD, P.J.-J. VAYSSE, P.R. HARTIG, T.A. BRANCHEK and R.E. WEINSHANK, EMBO J. 14 2806-2815 (1995).